Strados Logo
  • Technology
    • The RESP® Biosensor
      • For Remote Patient Monitoring »
      • For Life Sciences »
      • For Academic Research »
  • Therapeutic Areas
    • Asthma
    • Bronchiectasis
    • Chronic Cough
    • COPD
    • Pulmonary Fibrosis
  • About
  • Resources
    • News
    • Insights
    • Publications
    • Research Grant
  • Contact
Strados Labs to Present Developments in Cough Monitoring at ATS 2025

Strados Labs to Present Developments in Cough Monitoring at ATS 2025

by Strados Labs | Apr 22, 2025 | Events, Press Releases

Strados Labs looks forward to participating in the American Thoracic Society (ATS) 2025 International Conference from May 16–21 in San Francisco, CA. Please join us as we present sessions highlighting the importance of cough in respiratory diseases, along...
Webinar Replay: From Symptoms to Solutions: Enhancing Interstitial Lung Disease (ILD) Trials with Next-Gen Assessments

Webinar Replay: From Symptoms to Solutions: Enhancing Interstitial Lung Disease (ILD) Trials with Next-Gen Assessments

by Strados Labs | Apr 8, 2025 | Blog - Clinical Trial Focus, Events

Dr. Peter Cho’s section focused on cough in ILDs (on behalf of Strados Labs) from 28:52 – 39:40. Interstitial lung disease (ILD) represents a diverse group of disorders characterized by infiltration of lung parenchyma with extracellular matrix, leading to...
Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring

Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring

by Strados Labs | Mar 25, 2025 | Press Releases

The new program provides eligible research studies with in-kind support for the use of the RESP® Biosensor system. Philadelphia, PA, March 20, 2025 – Strados Labs, a medical technology company, is announcing the launch of a new grant initiative developed to accelerate...
Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained

Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained

by Strados Labs | Mar 11, 2025 | Blog - Clinical Trial Focus

Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects’ cough. As drug developers consider including cough frequency as an endpoint in their studies,...
Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema

Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema

by Strados Labs | Feb 20, 2025 | Press Releases

The study will evaluate continuous lung sound monitoring for the early detection of pulmonary edema and prevention of complications in critically ill ICU patients. Philadelphia, PA, February 20, 2025 — Strados Labs, a medical technology company focused on improving...
« Older Entries
Next Entries »

Recent Posts

  • Strados Labs Collaborates with Rutgers Robert Wood Johnson Medical School, RWJBarnabas Health to Evaluate Wearable Respiratory Monitoring in Cystic Fibrosis
  • Strados Labs Accelerates Research into Continuous Lung Sound Monitoring in 2025
  • From Stethoscope to Sensor: How We Developed a Lung Acoustics Wearable
  • Cough Counting Approaches Explained: Which One Is Best?
  • Takeaways from the ATS 2025 Innovation Hub Session: Tuning In To Cough In Pulmonary Fibrosis
Strados
Making Every Breath Count™
Offices
Philadelphia, PA
Atlanta, GA

Sitemap

  • About Strados
  • Support
  • Contact
  • Publications
  • Technical Specifications
  • FAQ
  • Careers

Follow Us





Get In Touch

1-888-STRADOS
Info@stradoslabs.com

Stay updated with news and insights!

Success!

Submit

© 2025 Strados Labs®  |  Privacy Policy  |   Cookie Policy